OverviewSuggest Edit

ACADIA Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address medical needs in related central nervous system (CNS) disorders. The Company has a pipeline of product candidates led by NUPLAZID (pimavanserin). 

TypePublic
Founded1993
HQSan Diego, US
Websiteacadia-pharm.com
Employee Ratings4.3

Locations

ACADIA Pharmaceuticals is headquartered in
San Diego, United States

Location Map

Latest Updates

Employees (est.) (Sep 2019)490(+3%)
Job Openings20
Revenue (FY, 2018)$223.8 M(+80%)
Share Price (Nov 2019)$46.1 (+2%)

Key People/Management at ACADIA Pharmaceuticals

Stephen R. Davis

Stephen R. Davis

President and Chief Executive Officer
Austin D. Kim

Austin D. Kim

Executive Vice President, General Counsel and Secretary
Michael J. Yang

Michael J. Yang

Executive Vice President, Chief Commercial Officer
Todd S. Young

Todd S. Young

Executive Vice President, Chief Financial Officer
Daryl Dekarske

Daryl Dekarske

Senior Vice President, Global Head of Regulatory Affairs
Robert Kaper

Robert Kaper

Senior Vice President, Global Head of Medical Affairs
Show more

ACADIA Pharmaceuticals Office Locations

ACADIA Pharmaceuticals has an office in San Diego
San Diego, US (HQ)
3611 Valley Centre Dr Suite 300
Show all (1)

ACADIA Pharmaceuticals Financials and Metrics

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals's revenue was reported to be $223.81 m in FY, 2018
USD

Revenue (Q3, 2019)

94.6m

Gross profit (Q3, 2019)

92.2m

Gross profit margin (Q3, 2019), %

97.4%

Net income (Q3, 2019)

(42.0m)

EBIT (Q3, 2019)

(45.4m)

Market capitalization (15-Nov-2019)

7.1b

Closing stock price (15-Nov-2019)

46.1

Cash (30-Sep-2019)

385.5m

EV

6.7b
ACADIA Pharmaceuticals's current market capitalization is $7.1 b.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.1m4.9m1.1m1.1m120.0k61.0k17.3m124.9m223.8m

Revenue growth, %

(90%)(49%)28311%

Cost of goods sold

3.1m9.1m

Gross profit

120.0k61.0k14.3m115.8m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

460.0k584.0k450.0k599.0k3.5m417.0k451.0k240.0k30.0k28.0k15.0k4.0k1.0k39.0k4.0k97.0k5.3m15.3m30.5m35.6m48.9m57.1m58.3m63.0m83.2m94.6m

Cost of goods sold

526.0k845.0k2.3m2.2m2.1m2.2m3.6m3.8m3.0m3.0m2.4m

Gross profit

(429.0k)4.4m13.0m28.3m33.4m46.7m53.5m54.5m60.0m80.2m92.2m

Gross profit Margin, %

(442%)84%85%93%94%96%94%93%95%96%97%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

6.9m57.9m11.7m61.9m102.1m163.6m69.4m134.8m

Accounts Receivable

5.9m17.3m26.1m

Prepaid Expenses

901.0k581.0k2.6m1.2m2.2m8.5m20.7m

Inventories

4.2m5.2m4.1m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

8.0m8.3m5.6m9.2m8.0m18.4m24.2m11.8m96.5m13.7m36.4m76.4m93.2m70.8m175.2m131.8m153.7m157.4m143.8m112.6m116.3m74.2m63.9m97.6m74.4m385.5m

Accounts Receivable

293.0k3.8m7.7m11.6m14.2m22.4m25.7m20.0m30.0m31.8m30.8m

Prepaid Expenses

654.0k613.0k463.0k426.0k627.0k1.5m1.3m2.5m1.9m3.1m2.1m1.3m1.1m2.0m4.3m6.8m5.1m6.9m8.0m14.6m13.0m12.8m15.0m23.7m18.5m21.4m

Inventories

2.9m4.3m3.9m6.0m5.5m5.6m4.7m4.3m4.6m3.8m4.8m
USDY, 2019

EV/EBIT

-148 x

EV/CFO

-55.4 x

Revenue/Employee

193.0k

Financial Leverage

1.1 x
Show all financial metrics

ACADIA Pharmaceuticals Operating Metrics

FY, 2016

Patents Issued

302
Show all operating metrics

ACADIA Pharmaceuticals Online and Social Media Presence

Embed Graph

ACADIA Pharmaceuticals Frequently Asked Questions

  • When was ACADIA Pharmaceuticals founded?

    ACADIA Pharmaceuticals was founded in 1993.

  • Who are ACADIA Pharmaceuticals key executives?

    ACADIA Pharmaceuticals's key executives are Stephen R. Davis, Austin D. Kim and Michael J. Yang.

  • How many employees does ACADIA Pharmaceuticals have?

    ACADIA Pharmaceuticals has 490 employees.

  • What is ACADIA Pharmaceuticals revenue?

    Latest ACADIA Pharmaceuticals annual revenue is $223.8 m.

  • What is ACADIA Pharmaceuticals revenue per employee?

    Latest ACADIA Pharmaceuticals revenue per employee is $456.7 k.

  • Who are ACADIA Pharmaceuticals competitors?

    Competitors of ACADIA Pharmaceuticals include BlueRock Therapeutics, Omeros and InVivo Therapeutics.

  • Where is ACADIA Pharmaceuticals headquarters?

    ACADIA Pharmaceuticals headquarters is located at 3611 Valley Centre Dr Suite 300, San Diego.

  • Where are ACADIA Pharmaceuticals offices?

    ACADIA Pharmaceuticals has an office in San Diego.

  • How many offices does ACADIA Pharmaceuticals have?

    ACADIA Pharmaceuticals has 1 office.